Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sirona launches new digital impression unit
Cerec AC is built on Sirona’s proprietary Cerec Bluecam technology and its automatic image capture system operates in such a way that entire quadrants can be scanned in
Cerec AC is built on Sirona’s proprietary Cerec Bluecam technology and its automatic image capture system operates in such a way that entire quadrants can be scanned in
As a prerequisite for approval of Cimzia, the FDA has requested a new safety update with all clinical data including new data generated since the filing of the
Most recently, Popovits served as as senior vice president, marketing and sales. She holds a B.A. in business from Michigan State University. Cole comes to Genomic in 2004
The PD2i Analyzer uses Vicor’s patented, proprietary point correlation dimension algorithm (PD2i), a deterministic, non-linear measure that analyzes ECG data to risk stratify target populations as to future
The final value of the MDS Pharma Services goodwill write-down, previously estimated to be in the range of $270 million to $370 million, is $320 million. Including the
The National Cancer Centre of Singapore (NCCS) said that it selected nimotuzumab because of its reported preferential safety profile compared with other epidermal growth factor receptor (EGFR)-targeting cancer
The company will conduct a Phase II trial in approximately 128 patients with non-small cell lung cancer (NSCLC) and a Phase II trial in approximately 88 patients with
Most recently serving as vice president of global sales and service and vice president of marketing and R&D. He has also held several senior marketing and product management
The Phase I/IIa trial is designed to assess the safety, tolerability and biological activity of the vaccine. CureVac expects to start the treatment of the first patient in
In his last position, he was a principal at a consulting firm he founded in 2002, providing high-level interim financial management and M&A services. Before that, Schmidt served